Show simple item record

dc.contributor.authorChing, Siew-Mooien
dc.contributor.authorChia, Yook-Chinen
dc.contributor.authorLentjes, Marleen AHen
dc.contributor.authorLuben, Roberten
dc.contributor.authorWareham, Nicholasen
dc.contributor.authorKhaw, Kay-Teeen
dc.date.accessioned2019-05-15T23:30:15Z
dc.date.available2019-05-15T23:30:15Z
dc.date.issued2019-05-03en
dc.identifier.issn1471-2458
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/292858
dc.description.abstractBACKGROUND: Our study aimed to determine the association between forced expiratory volume in one second (FEV1) and subsequent fatal and non-fatal events in a general population. METHODS: The Norfolk (UK) based European Prospective Investigation into Cancer (EPIC-Norfolk) recruited 25,639 participants between 1993 and 1997. FEV1 measured by portable spirometry, was categorized into sex-specific quintiles. Mortality and morbidity from all causes, cardiovascular disease (CVD) and respiratory disease were collected from 1997 up to 2015. Cox proportional hazard regression analysis was used with adjustment for socio-economic factors, physical activity and co-morbidities. RESULTS: Mean age of the population was 58.7 ± 9.3 years, mean FEV1 for men was 294± 74 cL/s and 214± 52 cL/s for women. The adjusted hazard ratios for all-cause mortality for participants in the highest fifth of the FEV1 category was 0.63 (0.52, 0.76) for men and 0.62 (0.51, 0.76) for women compared to the lowest quintile. Adjusted HRs for every 70 cL/s increase in FEV1 among men and women were 0.77 (p < 0.001) and 0.68 (p < 0.001) for total mortality, 0.85 (p<0.001) and 0.77 (p<0.001) for CVD and 0.52 (p <0.001) and 0.42 (p <0.001) for respiratory disease. CONCLUSIONS: Participants with higher FEV1 levels had a lower risk of CVD and all-cause mortality. Measuring the FEV1 with a portable handheld spirometry measurement may be used as a surrogate marker for cardiovascular risk. Every effort should be made to identify those with poorer lung function even in the absence of cardiovascular disease as they are at greater risk of total and CV mortality.
dc.description.sponsorshipThis work was supported by a Sabbatical programme awarded to Ching SM by Universiti Putra Malaysia. European Prospective Investigation into Cancer–Norfolk is funded by grants from the Medical Research Council UK (G9502233, G0401527) and Cancer Research UK (C864/A8257, C864/A2883). We further acknowledge core MRC Epidemiology Unit support through Programmes MC_UU_12015/1 and MC_UU_12015/5.
dc.format.mediumElectronicen
dc.languageengen
dc.publisherBioMed Central
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectHumansen
dc.subjectNeoplasmsen
dc.subjectRespiratory Tract Diseasesen
dc.subjectCardiovascular Diseasesen
dc.subjectRespiratory Function Testsen
dc.subjectVital Capacityen
dc.subjectForced Expiratory Volumeen
dc.subjectSpirometryen
dc.subjectMorbidityen
dc.subjectProportional Hazards Modelsen
dc.subjectRisk Factorsen
dc.subjectCohort Studiesen
dc.subjectFollow-Up Studiesen
dc.subjectProspective Studiesen
dc.subjectComorbidityen
dc.subjectResearch Designen
dc.subjectAdulten
dc.subjectAgeden
dc.subjectMiddle Ageden
dc.subjectFemaleen
dc.subjectMaleen
dc.subjectCoronary Artery Diseaseen
dc.titleFEV1 and total Cardiovascular mortality and morbidity over an 18 years follow-up Population-Based Prospective EPIC-NORFOLK Study.en
dc.typeArticle
prism.issueIdentifier1en
prism.publicationDate2019en
prism.publicationNameBMC public healthen
prism.startingPage501
prism.volume19en
dc.identifier.doi10.17863/CAM.40010
dcterms.dateAccepted2019-04-15en
rioxxterms.versionofrecord10.1186/s12889-019-6818-xen
rioxxterms.versionVoR
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserveden
rioxxterms.licenseref.startdate2019-05-03en
dc.contributor.orcidChing, Siew-Mooi [0000-0002-4425-7989]
dc.contributor.orcidLuben, Robert [0000-0002-5088-6343]
dc.contributor.orcidWareham, Nicholas [0000-0003-1422-2993]
dc.identifier.eissn1471-2458
rioxxterms.typeJournal Article/Reviewen
pubs.funder-project-idMRC (MC_UU_12015/1)
pubs.funder-project-idDepartment of Health (via National Institute for Health Research (NIHR)) (NF-SI-0617-10149)
pubs.funder-project-idMRC (G1000143)
pubs.funder-project-idMRC (G0401527)
pubs.funder-project-idMRC (MC_UU_12015/5)
pubs.funder-project-idCancer Research UK (A8257)
pubs.funder-project-idCancer Research UK (A2883)
pubs.funder-project-idMEDICAL RESEARCH COUNCIL (MR/N003284/1)


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution 4.0 International
Except where otherwise noted, this item's licence is described as Attribution 4.0 International